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ABSTRACT
Peptidases (proteolytic enzymes) and their natural,
protein inhibitors are of great relevance to biology,
medicine and biotechnology. The MEROPS database
(http://merops.sanger.ac.uk)aimstofulfiltheneedfor
an integrated source of information about these pro-
teins.Theorganizationalprincipleofthedatabaseisa
hierarchical classification in which homologous sets
of proteins of interest are grouped into families and
the homologous families are grouped in clans. The
most important addition to the database has been
newly written, concise text annotations for each pep-
tidase family. Other forms of information recently
added include highlighting of active site residues
(or the replacements that render some homologues
inactive) in the sequence displays and BlastP search
results, dynamically generated alignments and trees
at thepeptidase orinhibitorlevel,and acuratedlistof
human and mouse homologues that have been
experimentally characterized as active. A new way
to display information at taxonomic levels higher
than species has been devised. In the Literature
pages,referenceshavebeenflaggedtodrawattention
to particularly ‘hot’ topics.
INTRODUCTION
The MEROPS database is a manually curated information
resource for proteolytic enzymes (best termed peptidases)
and their protein inhibitors. The database has been in existence
since 1996 and may be found at http://merops.sanger.ac.uk.
The importance of peptidases and their inhibitors is illus-
trated by the fact that 18% of sequences in the SwissProt
database are annotated as undergoing proteolytic processing,
2% of all genes encode peptidases and their homologues in
all kinds of organisms, and that there are over 550 active and
putative peptidases in the human genome. The MEROPS clas-
siﬁcation of peptidases, founded in 1993 (1), is a classiﬁcation
at the protein domain level (we term the domain in question
the peptidase unit) and is hierarchical. Homologues that are
biochemically similar are given the same identiﬁer, and for
each identiﬁer a holotype is nominated. Proteins with homo-
logous peptidase units are grouped in a family. Every member
of the family has to be shown to be related to a nominated type
example. Families are grouped in a clan if there are indica-
tions, principally from tertiary structure similarities, that there
was a common ancestor. The same principles have been used
to classify the protein inhibitors of peptidases (2). The inhib-
itors are not as widely distributed as peptidases, with only one
or two known from each bacterial or archaean genome. In the
human genome, there are 105 known inhibitors and a further
176 homologues that are not known to be inhibitory.
Statistics from release 7.1 (July 2005) of MEROPS are
shown in Table 1 and compared with release 6.3 from June
2003. Although the number of sequences classiﬁed as pepti-
dase homologues has nearly doubled, these have mostly been
additions to existing families, and only eight new peptidase
families have been discovered since June 2003.
FAMILY SUMMARIES
We have added text summaries for all peptidases families.
Each summary is structured under the following headings,
with a brief description of the contents:
(i) Content of family: a description of the catalytic type and
whether the peptidases in the family are endopeptidases
or exopeptidases (aminopeptidases, carboxypeptidases,
etc.) or a mixture.
(ii) History: when peptidases in the family were first discov-
ered and other essential background information.
Table 1. Counts of identifiers, families and clans for peptidase and protein
inhibitor homologues in the MEROPS database
MEROPS 7.1 Inhibitors MEROPS 6.3 Inhibitors
Peptidases Peptidases
Sequences 30909 3690 18076 2651
Identifiers 2053 532 1711 318
Families 180 53 172 48
Clans 39 32 33 25
for release 6.3 (June 2003).
Counts are shown for release 7.1 of the MEROPS database (July 2005) and
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doi:10.1093/nar/gkj089(iii) Active site: the residues that are important for catalysis,
including metal ligands for metallopeptidases, and
describingthevariabilityofaminoacidsateachposition.
(iv) Activities and specificities: reaction conditions and
example substrates.
(v) Inhibitors: predominantly lists small molecule inhibitors
that can be used to distinguish members of the family.
(vi) Molecular structure: if the tertiary structure has been
determined for any member of the family, then the fold
isdescribedandcomparedwithothers.Alsoincludedhere
are domain organization and conservation of features,
such as disulfide bridges and transmembrane regions.
(vii) Distributionoffamily:thisisincludedwhenthedistribu-
tionamongorganismsisunusual,e.g.C51whichisfound
only in bacteriophages that infect staphylococci.
(viii) Biological functions: examples of known physiological
and pathological roles.
(ix) Pharmaceutical and biotech relevance: peptidases in the
family that are drug targets or have industrial uses.
Summaries have also been written for families of protein
inhibitors.Theheadingsarecontentoffamily,history,reactive
site, peptidase inhibited, molecular structure and distribution
of family.
FLAGGING OF TOPICS IN LITERATURE PAGES
The literature on peptidases is large, and the Literature pages
in MEROPS contain well over 20000 references. So that it
may be easier to spot a paper on a particular topic in a Lit-
erature page, we have added ‘ﬂags’ for six important topics.
Thus, ‘E’ indicates that the paper contains information on the
recombinant Expression of a peptidase; ‘I’ shows that we
found the article to be relevant to the design of Inhibitors
for the enzyme; ‘K’ means that the paper deals with a gene
Knockout or other artiﬁcial genetic manipulation; ‘M’ shows
that the paper deals with a natural Mutation, allelic variant or
polymorphism; ‘R’ indicates that the article includes informa-
tion about an RNA splicing variant; ‘S’ means that the
article deals with 3D Structure; and ‘V’ shows that the article
is a review.
HIGHLIGHTINGINSEQUENCEDISPLAYS,FAMILY
PAGES AND BLASTP RESULTS
Active site residues tend to be highly conserved because of the
restraints imposed by the catalytic function. For this reason,
even unrelated peptidases may have similar or even superim-
posable active sites. For example, the serine, histidine, aspart-
ate catalytic triad is found in trypsin (family S1, clan PA),
subtilisin(familyS8,clanSB) andcarboxypeptidaseY(family
S9, clan SC), although the order of the residues is different and
the tertiary folds are completely different. Many peptidase
families contain homologues that are not peptidases because
one or more active site residues has been changed (though
we stress that in some families there are enzymes other
than peptidases that possess a matching set of active site resi-
dues and/or metal ligands, such as succinyl-diaminopimelate
desuccinylase in family M20). In our annotated family
alignments, we adopted the convention of showing active
site residues as white text on a red background, metal ligands
as white text on a blue background and replacements of either
as white text on a black background. We have now extended
the highlighting to our sequence displays, family summaries
and BlastP search results.
Inourdisplayofeach sequenceinFastAformat(3), notonly
do we highlight active site residues and metal ligands, but we
also highlight the peptidase (or inhibitor) unit in red. We also
show when a peptidase unit is interrupted by an unrelated
(‘nested’) domain (for example the ﬁbronectin-like repeats
in gelatinase A). The residues are now numbered and the
header line includes the range of the peptidase (or inhibitor)
unit and residue numbers of catalytic residues.
We have enhanced the service whereby a user may submit a
sequence and search our collection of peptidase sequences
usingtheBlastPprogram(4)with newannotationoftheBlastP
results that shows active site residues according to our stand-
ard conventions. This allows the user to tell at a glance
whether the query sequence is likely to be a peptidase or not.
Highlighting of reactive site residues is not appropriate for
the protein inhibitors, because the reactive site residue is
highly variable within a family.
In the label ﬁle for each family alignment and tree, we now
highlight the holotypes as well as the family type example.
ALIGNMENTS AND TREES AT THE PEPTIDASE/
INHIBITOR LEVEL
We have always provided alignments and trees derived from
them for every family in MEROPS, but we now generate
dynamically an alignment and tree for every peptidase and
protein inhibitor. The family alignments show only the pep-
tidase orinhibitorunits,butthe new option also allowsthe user
to select the complete sequence to align. We expect every
peptidase or inhibitor assigned to the same identiﬁer to
have sequence similarity from N-terminus to C-terminus.
An alignment at the identiﬁer level is generated by MUSCLE
(5); this alignment is used to generate a Neighbor-joining tree
(6) using QuickTree (7) which is displayed using the Clustal-
Tree Java applet written by Rodrigo Lopez and Stephen
Robinson at the European Bioinformatics Institute.
PEPTIDASES AND INHIBITORS AT THE
ORGANISM LEVEL
The index of organism names now includes English common
names and synonyms of scientiﬁc binomials. This helps the
user to ﬁnd the organism of interest.
For each organism from which a peptidase is known, we list
an abbreviated taxonomy (superkingdom, kingdom, phylum,
subphylum, superclass, class, subclass, superorder, order, sub-
order, superfamily, family, subfamily and genus) and all the
known peptidase homologues. As an aid to examining the
distribution of peptidases among organisms, we now provide
a tool to display the peptidase (or protein inhibitor) data at all
higher levels in the taxonomy table in each organism page. For
example, on consulting the Plasmodium falciparum page, a
user might ﬁnd it useful to know how these peptidases are
distributed among all Plasmodium species, and clicking on
the genus level in the taxonomy table will display just that.
Knowing that a peptidase is present in one pathogen but
Nucleic Acids Research, 2006, Vol. 34, Database issue D271not another could indicate whether the peptidase is a potential
drug target.
The Organism page has been made more interactive so that
the user can sort the data by clan, family, peptidase or inhib-
itor, or gene name by simply clicking at the top of the appro-
priate column. By default, the list is sorted by family.
The user can now obtain all the peptidase (or inhibitor) unit
sequences foreach organisminFastAformatby clicking alink
at the top of each Organism page.
ACTIVITY STATUS OF HUMAN AND
MOUSE PEPTIDASES
In general, we create an identiﬁer for a peptidase when it is
clear that it can be distinguished biochemically or functionally
from other members in the family. However, we have created
an identiﬁer foreach human and mouse peptidase andinhibitor
homologue. Although the creation of an identiﬁer for a Droso-
phila melanogaster peptidase immediately implies that the
peptidase is active, this is not the case for a human or
mouse peptidasehomologue. Consequently, we have reviewed
the literature for evidence of proteolytic activity for every
human and mouse peptidase homologue and included refer-
ences on each peptidase page. We state whether we currently
regard the homologue as an ‘active’, ‘putative’ or ‘inactive’
peptidase homologue. If we are aware that a peptidase has
been shown experimentally to be active, we give a reference,
and if on the other hand we believe it to be inactive because
one or more expected active site residues are replaced, this is
indicated according to the convention described above. See
Table 2 for examples.
In the human genome, there are 440 peptidase homo-
logues that we believe are inactive against peptide
substrates.
SUMMARY
The collection and analysis of peptidase and protein inhibitor
sequences hasnowbeen largelyautomated,andsothe thrustof
the MEROPS database for the past 2 years has been towards
increased annotation, and we intend to extend this in the future
with summaries for inhibitor families, and clans of peptidases
and inhibitors.
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Table 2. Examples of annotation of activity status of human and mouse
peptidase homologues
MEROPS
identifier
Recommended
name
Activity status
(reference)
A01.007 Renin Human: active (Suzuki et al., 2004)
Mouse: active (Hansen et al., 2004)
S09.018 Dipeptidyl-
peptidase 8
Human: active (Chen et al., 2004)
Mouse: active (by similarity to human)
S09.973 Dipeptidylpeptidase
homologue DPP6
Human: inactive; SDH
Mouse: inactive; SDH
For non-peptidase homologues, conserved active site residues are shown as
whitetextonaredbackground,andresiduesthathavebeenreplacedareshown
as white text on a black background.
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